Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt
· Delayed Price · Currency is EGP 2.050
+0.020 (0.99%)
At close: Mar 27, 2025
EGX:MCRO Revenue
In the year 2024, Macro Group Pharmaceuticals (Macro Capital) S.A.E had annual revenue of 519.97M EGP, down -1.15%. Macro Group Pharmaceuticals (Macro Capital) S.A.E had revenue of 200.76M in the quarter ending December 31, 2024, a decrease of -416.04%.
Revenue
519.97M
Revenue Growth
-1.15%
P/S Ratio
2.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 519.97M | -6.04M | -1.15% |
| Dec 31, 2023 | 526.01M | -203.61M | -27.91% |
| Dec 31, 2022 | 729.61M | 135.35M | 22.78% |
| Dec 31, 2021 | 594.26M | 163.76M | 38.04% |
| Dec 31, 2020 | 430.50M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Commercial International Bank Egypt (CIB) S.A.E. | 114.75B |
| El Sewedy Electric Company | 231.98B |
| Talaat Moustafa Group Holding | 42.67B |
| Eastern Company S.A.E | 30.98B |
| Misr Fertilizer Production Company | 19.65B |
| Egypt Aluminum | 40.94B |
| Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.) | 20.16B |
| Qatar National Bank | 42.70B |